Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
4.730
-0.140 (-2.87%)
At close: Dec 12, 2025, 4:00 PM EST
4.740
+0.010 (0.21%)
After-hours: Dec 12, 2025, 6:40 PM EST
Nyxoah Market Cap
Nyxoah has a market cap or net worth of $210.36 million as of December 12, 2025. Its market cap has decreased by -29.21% in one year.
Market Cap
210.36M
Enterprise Value
208.81M
1-Year Change
-29.21%
Ranking
Category
Stock Price
$4.73
Market Cap Chart
Since the IPO on February 9, 2021, Nyxoah's market cap has decreased from $506.14M to $210.36M, a decrease of -58.44%. That is a compound annual growth rate of -16.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 210.36M | -34.28% |
| Dec 31, 2024 | 320.06M | 137.05% |
| Dec 29, 2023 | 135.02M | -4.90% |
| Dec 30, 2022 | 141.98M | -73.96% |
| Dec 31, 2021 | 545.17M | 7.71% |
| Feb 9, 2021 | 506.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 903.78B |
| Johnson & Johnson | 505.98B |
| AbbVie | 395.86B |
| UnitedHealth Group | 305.02B |
| AstraZeneca | 282.91B |
| Novartis AG | 256.01B |
| Merck & Co. | 245.75B |
| Novo Nordisk | 223.42B |